The GDx nerve fibre analyser, made by
Zeiss, is the most sensitive early screening test for glaucoma available.
The following is an extract from the RNIB website:
In the UK some form of glaucoma affects about two in
100 people over the age of 40 and five in 100 people over the age of 75. Our
research shows that four out of five people have heard of glaucoma but that
their understanding is limited, especially about the groups of people who
are at higher risk of developing the condition. These are:
|people of African or Asian origin |
|people with close relatives (father, mother,
brother, sister) who have the condition |
|people over 40 |
|people with very short sight (severe myopia).
Glaucoma has no symptoms in its early stages and up to
40 per cent of useful sight can be lost before a person realises they have
the condition. Regular eye tests are crucial in detecting glaucoma early.
Once diagnosed, treatment involves using eye drops and as long as the
programme is followed, further sight loss can be minimised."
The above shows that
early diagnosis is crucial to the
preservation of sight. With the GDx we hope to offer peace of
mind to anyone who chooses to have the test done, and the possibility of
treatment to anyone found to be in the early stages of the condition. The
test does not involve contact with the eye, and takes only a few minutes.
For a list of our professional fees, please contact us
by phone, email or fax or
call into the practice.